OcuTerra Therapeutics, Inc.

Pharmaceutical company · Boston, Massachusetts, United States

OcuTerra Therapeutics, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. It has reported private securities offerings to the US SEC, most recently $32 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

OcuTerra Therapeutics at a glance

Typepharmaceutical company

HeadquartersBoston, Massachusetts, United States

SEC CIK1641226

What does OcuTerra Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $31.5 million sold (2021).

Frequently asked questions about OcuTerra Therapeutics

Where is OcuTerra Therapeutics headquartered?

OcuTerra Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

What does OcuTerra Therapeutics do?

OcuTerra Therapeutics, Inc. is a pharmaceutical company.

Similar companies

Transcode Therapeutics, Inc.Boston, Massachusetts, United States
Akouos, Inc.Boston, Massachusetts, United States
Astria Therapeutics, Inc.Boston, Massachusetts, United States
Albireo Pharma, Inc.Boston, Massachusetts, United States
Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
Tango Therapeutics, Inc.Boston, Massachusetts, United States
Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences